The hepatitis B vaccine is one of the most potent immunizations, usually providing decades of protection against the deadly liver virus. But in about 10% of people it doesn’t work, and in 2020, Amy Huei-Yi Lee, a systems biologist at Simon Fraser University, and her colleagues set out to determine whether they could predict who would benefit. The scientists found that data on recipients’ immune systems such as the abundance of certain proteins and the activity patterns of a few genes foretold whether they would generate defenses against the virus. “We got a sense of what factors drive the vaccine response and what [doesn’t],” Lee says.
Trending
- No ranching without Benue people’s consent, Alia vows
- Falana faults NBA over Weah invitation, urges Bar to avoid ‘dictators’
- Sokoto begins screening for midwifery scholarship scheme
- [VIEWPOINT] The numbers are improving, but are Nigerians? By Prof. Chiwuike Uba, PhD
- Farmers urge govt to boost agro-business for food security
- KADA deploys climate-smart technologies to boost farm productivity
- NCC commits to inclusive digital innovation for PWDs
- SPHPN calls for stronger collaboration with lawmakers on healthcare
